Strikingly, CCL3 and CCL4 also comprise 2 of the immune genes with reproducibly increased expression in BL compared with WH prostate tumors, a finding replicated in multiple independent array-based studies (20, 26, 54) but conspicuously absent from RNA-Seq–based studies such as TCGA (Supplemental Figure 14). The gene discussed is CCL3; the disease is prostate neoplasm.